Fibroblast Growth Factor Receptor 1 Rearranged Myeloproliferative Neoplasm (MLN-FGFR1) in a Pediatric Patient; Challenging Diagnosis and Treatment Approach
Publication
, Journal Article
McCarty, K; Zheng, S; Simms-Waldrip, T; Shliakhtsitsava, K
Published in: Blood
November 5, 2024
Duke Scholars
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 5, 2024
Volume
144
Issue
Supplement 1
Start / End Page
6671 / 6671
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
McCarty, K., Zheng, S., Simms-Waldrip, T., & Shliakhtsitsava, K. (2024). Fibroblast Growth Factor Receptor 1 Rearranged Myeloproliferative Neoplasm (MLN-FGFR1) in a Pediatric Patient; Challenging Diagnosis and Treatment Approach. Blood, 144(Supplement 1), 6671–6671. https://doi.org/10.1182/blood-2024-203875
McCarty, Kyra, Sisi Zheng, Tiffany Simms-Waldrip, and Ksenya Shliakhtsitsava. “Fibroblast Growth Factor Receptor 1 Rearranged Myeloproliferative Neoplasm (MLN-FGFR1) in a Pediatric Patient; Challenging Diagnosis and Treatment Approach.” Blood 144, no. Supplement 1 (November 5, 2024): 6671–6671. https://doi.org/10.1182/blood-2024-203875.
McCarty K, Zheng S, Simms-Waldrip T, Shliakhtsitsava K. Fibroblast Growth Factor Receptor 1 Rearranged Myeloproliferative Neoplasm (MLN-FGFR1) in a Pediatric Patient; Challenging Diagnosis and Treatment Approach. Blood. 2024 Nov 5;144(Supplement 1):6671–6671.
McCarty, Kyra, et al. “Fibroblast Growth Factor Receptor 1 Rearranged Myeloproliferative Neoplasm (MLN-FGFR1) in a Pediatric Patient; Challenging Diagnosis and Treatment Approach.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, Nov. 2024, pp. 6671–6671. Crossref, doi:10.1182/blood-2024-203875.
McCarty K, Zheng S, Simms-Waldrip T, Shliakhtsitsava K. Fibroblast Growth Factor Receptor 1 Rearranged Myeloproliferative Neoplasm (MLN-FGFR1) in a Pediatric Patient; Challenging Diagnosis and Treatment Approach. Blood. American Society of Hematology; 2024 Nov 5;144(Supplement 1):6671–6671.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 5, 2024
Volume
144
Issue
Supplement 1
Start / End Page
6671 / 6671
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology